Alkaloid AD Skopje

ALK

MKALKA101011

Pharmaceuticals

End-of-day quote MACEDONIAN S.E. Other stock markets
- ^MKD	-

Jan. 15	Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Alkaloid AD Skopje Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Alkaloid Skopje : Other decisions of the shareholders meeting

April 04, 2022 at 08:37 am EDT

According to the Chapter 6 of the Listing Rules, we are publishing the following information

Other resolutions of the shareholders assembly

T1. Resolution for Chair of the Assembly.pdf
T2. Resolution for Еlection of vote counters.pdf
T3. Resolution for adoption of the amendments of the Statute of ALKALOID AD Skopje.pdf
T4. Resolution for adoption of the Rules of Procedure for the Assembly.pdf
T5. Resolution to approve and adopt the Annual Report for 2021.pdf
T6. Resolution to approve and adopt the Annual Account and Financial Statements for 2021.pdf
T6. Resolution to approve the performance of the Management Board in 2021.pdf
T7. Resolution to adopt the reports on the audit performed by the authorised auditor.pdf
T8. Resolution to approve the performance of the Supervisory Board in 2021.pdf
T13. Resolution on appointment of an authorized auditor for 2022.pdf

Attachments

Original Link
Original Document
Permalink

Disclaimer

Alkaloid AD Skopje published this content on 04 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 April 2022 12:36:10 UTC.

Latest news about Alkaloid AD Skopje

Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 14	CI
Alkaloid AD Skopje Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-26	CI
Alkaloid AD Skopje Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-14	CI
Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-26	CI
Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2021	22-01-14	CI
Alkaloid Ad Skopje Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-29	CI
Alkaloid Ad Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Alkaloid Ad Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-25	CI
Alkaloid Ad Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-14	CI
Alkaloid Ad Reports Earnings Results for the Half Year Ended June 30, 2020	20-07-30	CI
Alkaloid Ad Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-30	CI
Alkaloid AD's Equity Buyback announced on March 12, 2020, has expired.	20-04-06	CI
Alkaloid AD(MSE:ALK) commences an Equity Buyback for 10% of its issued share capital, under the authorization approved on April 8, 2019.	20-03-12	CI
Alkaloid Ad Reports Earnings Results for the Full Year Ended December 31, 2019	20-02-28	CI
Alkaloid Ad Skopje Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-30	CI
Alka-Lab announced that it has received €0.4 million in funding from Alkaloid AD	19-07-22	CI
Alkaloid Ad Reports Earnings Results for the Full Year Ended December 31, 2018	19-02-27	CI
ICC International Cannabis Corp. (CNSX:WRLD.U) acquired an unknown stake in Alkaloid AD.	19-01-23	CI
Alkaloid Ad Skopje Reports Earnings Results for the Nine Months Ended September 30, 2018	18-10-31	CI
Alkaloid Reports Consolidated Earnings Results for the First-Quarter of 2017	17-04-27	CI
Alkaloid Reports Unaudited Consolidated and Standalone Earnings Results for the Year Ended December 2016	17-02-28	CI
Alkaloid Reports Consolidated Financial Results for the First Nine Months Ended September 2016	16-11-03	CI
Alkaloid AD Reports Unaudited Consolidated Earnings Results for the First Half Ended June 2016	16-07-29	CI
Alkaloid Reports Consolidated Earnings Results for the First Quarter Ended March 2016	16-04-28	CI
Alkaloid Plans to Expand Presence in Russian Market Via Serbia	16-03-31	CI

Chart Alkaloid AD Skopje

Duration

Period

More charts

Company Profile

Alkaloid AD Skopje is a Macedonia-based company active in the pharmaceutical sector. It is engaged in the manufacturing and distribution of pharmaceuticals, the processing of herbal materials and the production of cosmetics, tea, chemical products and coating agents. It operates through two divisions: Pharmaceuticals, and Chemicals, Cosmetics and Botanicals. The Companyâs product range includes human drugs, x-ray films, haemodialysis solutions, pharmaceutical raw materials, animal health products, perfumes, household cosmetics, skin, teeth and hair care products, tea and alimentary products. It also operates a development institute for analysis, research and quality control, warehouses and laboratories. The Company operates more than 13 subsidiaries in such countries as Croatia, Serbia, Slovenia, Bosnia and Herzegovina, Bulgaria, Kosovo, the Untied States, Montenegro and the Russian Federation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ALKALOID AD SKOPJE	0.00%	0
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.81%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+11.60%	14.09B
CIPLA LIMITED	+12.97%	13.64B
ZYDUS LIFESCIENCES LIMITED	+39.74%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B